Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Characteristics of the study population

From: Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study

Variables No hip fracture n (%) Hip fracture n (%) % of the population
All 37 612 (98) 795 (2) 100
Men 14 800 (39) 210 (26) 39
Women 22 812 (61) 585 (74) 61
Age (years)    
75-79 13 337 (36) 108 (14) 35
80-84 11 859 (32 231 (29) 31
85- 12 416 (33) 456 (57) 34
Multimorbidity level    
RUB 0 4 058 (11) 55 (7) 11
RUB 1 2 157 (6) 37 (5) 6
RUB 2 6 080 (16) 96 (12) 16
RUB 3 19 545 (74) 386 (49) 52
RUB 4 4 308 (11) 148 (19) 12
RUB 5 1 325 (4) 69 (9) 4
Use of FRIDs    
Cardiovascular drugs    
  Vasodilators used in cardiac diseases 7 092 (19) 166 (21) 19
  Antihypertensive agents 191 (0.5) 4 (0.5) 0.5
  Diuretics 17 309 (46) 425 (53) 47
  Beta-blocking agents 16 399 (44) 339 (43) 44
  Calcium channel blockers 8 054 (21) 145 (18) 21
  Renin-angiotensin system inhibitors 12 109 (32) 237 (30) 32
Alpha-adrenoreceptor antagonists 0 0 0
Psychotropic drugs    
  Opioids 7 336 (20) 262 (33) 20
  Dopaminergic agents 849 (2) 33 (4) 2
  Antipsychotics excluding lithium 1 411 (4) 52 (7) 4
  Anxiolytics 6 096 (16) 201 (25) 16
  Hypnotics and sedatives 9 483 (25) 295 (37) 25
  Antidepressants 6 061 (16) 227 (29) 16